Faculty Information |
|
Language | English |
The announcement title | A phase II study of gemcitabine, cisplatin, and bevacizumab for first recurrent and refractory ovarian clear-cell carcinoma (KCOG-G1601 trial) |
Academic Society name | ESMO Virtual Congress 2020 |
Conference Type | International Society |
Announcement form | Web announcement |
Presentation Type | General Lecture |
Lecture Type | 一般 |
Publisher and common publisher | Ito Kimihiko, Nakagawa Mio, Hori Kensuke, Tashima Lena, Goto Mayako, Yanagida Satoshi, Suzuki Jiro, Kaya Ryusuke, Kawabata Ayako, Yamada Kyosuke, Park Jongmyung, Nasu Hiroki, Nishio Shin, Eiji Kondo, Kaneda Michiko, Tsubamoto Hiroshi, Arakawa Atsushi, Nagasawa Takayuki |
Date | 2020/09/19 |
Venue (city and name of the country) |
Web |